Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Unrecognized Tax Benefits that Would Impact Effective Tax Rate

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate

VISTAGEN THERAPEUTICS, INC. (VTGN) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $0 as of 2026-03-31, per its 10-K filed 2026-06-15.

Financial Statements › Notes › Income Taxes › Income Tax Uncertainties

us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-06-15

  • 2026-03-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
  • 2025-03-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
  • 2024-03-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
  • 2023-03-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
Period endUnrecognized Tax Benefits that Would Impact Effective Tax Rate
2026-03-31$0.00
10-K · filed 2026-06-15
2025-03-31$0.00
10-K · filed 2026-06-15
2024-03-31$0.00
10-K · filed 2025-06-17
2023-03-31$0.00
10-K · filed 2024-06-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B